Neglected Disease Efforts Require Delicate Balance

View on BioWorld Today website

Date

Feb. 24, 2008

News Type

Media Highlight

Source

BioWorld Today

Ramanan Laxminarayan encourages the use of advance market commitments to encourage the biotech and pharmaceutical industries to engage in research and development for drugs to treat neglected diseases.

Related Content

Common Resources — Sep 9, 2025

What are Renewable Energy Credits Good For?

Renewable energy credits can help reduce risks associated with clean energy projects. Understanding the benefits, and potential drawbacks, of these credits will be important in deciding their broader role in the clean energy transition.

Resources Radio — Sep 9, 2025

The Role of Government Agencies in Wildlife Abundance, Decimation, and Recovery, with Dominic Parker

Dominic Parker discusses the first government-run environmental agencies in the United States—state wildlife agencies—and their influence on the survival of US wildlife.

Common Resources — Sep 4, 2025

If/Then: Sunsetting Energy Regulations

If the Federal Energy Regulatory Commission and other agencies implement executive orders to sunset energy regulations without careful analysis, then the agencies may depart from decades-long precedent and face legal and practical challenges.

Resources Radio — Sep 2, 2025

Sweating Over Student Behavior in Hot Schools, with Kristen McCormack

Kristen McCormack, Resources for the Future’s newest research fellow, discusses the impact of extreme temperatures on student behavior, absences, disciplinary referrals, and later-life outcomes.